[1] |
DUAN Meng, DONG Bingqi, LIAO Zhikai, LEI Tiechi.
Stimulation of cathelicidin in cultured human keratinocytes by Substance P via the activation of nuclear factor NF-κB
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 403-408.
|
[2] |
WANG Tiyan, ZHOU Xiaohong.
Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 413-416.
|
[3] |
ZHANG Anping, ZHANG Xuejun.
Update of total glucosides of paeony in treatment of the immune-associated dermatoses
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(4): 306-310.
|
[4] |
LIU Jian, ZHANG Zhiqin, YIN Zhiqiang.
Update of relationship between regulated cell death and psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 206-211.
|
[5] |
FANG Meng, JIA Fengming, LIU Hong.
Update of treatment of psoriasis in pregnancy
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(2): 142-147.
|
[6] |
HUANG Liangmei, SHI Jianqiang.
Update of endoplasmic reticulum resident protein UNC93B1 and TLR7 in systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(1): 51-55.
|
[7] |
LI Mengmeng, LI Jingyi, LIU Qingfeng, LIU Youqing, LI Wei.
Clinical efficacy and safety of dupilumab in the treatment of moderate and severe atopic dermatitis for 16 weeks
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(12): 849-852.
|
[8] |
LI Jinzhuo, LIN Zhipeng, ZENG Qianwen, SUN Renshan.
Update on the effect of PM2.5 on skin keratinocytes
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 537-542.
|
[9] |
SUN Jie, WANG Rui, HUANG Min, BAI Jia, LI Chengxin.
Effect of IL-17A on insulin resistance in keratinocytes
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 271-275.
|
[10] |
HAN Yue, YAO Xu.
Activation and inflammation of HaCaT Cells regulated by exosomes in peripheral blood of the patients with atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 70-74.
|
[11] |
YANG Baoqi, ZHANG Zhaoxia, CHEN Mingfei, WANG Na, YAN Xiaoxiao, YANG Qing, PAN Futang, WANG Guangjin, DU Donghong, WU Mei, SHI Zhongxiang, ZHANG Furen.
Treatment of pemphigus with rituximab: report of six cases and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 718-721.
|
[12] |
ZHU Jianwei, LUO Dan.
Down-regulation of IFN-γ-induced over-expression of surface antigens on normal human keratinocytes by UVB
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(1): 16-19.
|
[13] |
WANG Meiling, LIU Huaxu.
Update of the pathogenesis and therapeutic mechanism of port wine stain
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(9): 564-567.
|
[14] |
QIAN Jiali, HE Jingyan, SUN Liyun.
Efficacy and safety of three-times dose of Ebastine in the treatment of mild to moderate atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(2): 70-72.
|
[15] |
LI Yuanyuan, SHE Huihui, QIAN Longbao, WEI Shicai.
Effect of keratinocyte and fibroblast on the pathogenesis and treatment of vitiligo
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(11): 701-704.
|